Skip to content
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • Host Response
    • SeptiCyte™ LAB
    • SeptiCyte™ RAPID
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • Host Response
    • SeptiCyte™ LAB
    • SeptiCyte™ RAPID
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us

Media Contacts

If you are a member of the media, please contact:

Maggie Beller

Russo Partners

(646) 942-5631

maggie.beller@russopartnersllc.com

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom

Contact Us

Privacy policy

 

Tweets by @Immunexpress

© 2021 Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 430, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com

Scroll To Top
We use cookies to ensure that we give you the best experience on our website. Continuing to use this website means you're ok with this. For more information about how we use cookies see our privacy policy.OkPrivacy policy